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OBJECTIVES We studied the relationship between coronary artery calcium (CAC) and race in asymptom-
atic, active-duty personnel in the Prospective Army Coronary Calcium (PACC) project.
BACKGROUND Valid cardiovascular risk assessments in black Americans using coronary artery computed
tomography (coronary CT) require the generalizability of population-based CAC score
distributions derived from primarily white patient populations.
METHODS Among 1,000 consecutive participants (mean age, 42  2 years; range, 40 to 45 years), 999
participants underwent coronary CT and indicated a specific racial affiliation. This included white,
non-Hispanic in 699 (69.9%) participants and black, non-Hispanic in 194 (19.4%) participants.
Univariate associations between race and cardiovascular risk variables were entered into a logistic
regression model for CAC that also controlled for socioeconomic status and education.
RESULTS Coronary artery calcium was nearly twice as prevalent in white (19.2%) than in black
participants (10.3%) (p  0.004). Black individuals had a threefold greater prevalence of
hypertension, left ventricular hypertrophy, ST-T-wave abnormalities, and current cigarette
smoking. Black subjects also had significantly greater blood pressure, high-density lipoprotein
cholesterol, glycosylated hemoglobin, lipoprotein(a) and fibrinogen levels, and lower triglyc-
eride levels and waist girth than white subjects. After adjustment for these differences, and
socioeconomic adjusters, black individuals were 39% as likely to have any CAC present (odds
ratio, 0.39; 95% confidence interval, 0.20 to 0.78; p  0.007).
CONCLUSIONS Despite a worse cardiovascular risk profile, black Americans have significantly less CAC than
white Americans. The use of coronary CT as an accurate risk prediction tool in black
Americans will require ethnic-specific data on the presence and severity of CAC. (J Am
Coll Cardiol 2003;41:39–44) © 2003 by the American College of Cardiology Foundation
The presence of extensive age- and gender-adjusted coro-
nary artery calcium (CAC) on coronary artery computed
tomography (coronary CT) indicates a higher than expected
atherosclerotic burden and greater absolute and relative risk
for the development of incident coronary heart disease
(1–4). Thus, this test is increasingly applied as a tool to
measure cardiovascular risk. However, coronary CT-based
risk assessments utilize age- and gender-specific CAC
See page 45
distributions derived from predominately white, male, and
well-educated patients (5,6). The generalizability of coro-
nary CT as a risk-screening tool to other ethnic groups, for
example, black individuals, is critically dependent on cross-
ethnic stability in these CAC distributions. Major interra-
cial differences in cardiovascular risk factors associated with
CAC, such as hypertension and hyperlipidemia, and in
calcium and bone metabolism (7–9) provide the rationale
for validating the assumption that coronary CT scores have
cross-ethnic validity.
Previous studies on race and CAC have yielded discrep-
ant results. In a study using digital fluoroscopy, Doherty et
al. (10) found a significantly lower prevalence of CAC yet
higher cardiovascular event rates in black individuals. More
recently, the Coronary Artery Risk Development in Young
Adults study (CARDIA) reported an absence of racial
differences in the prevalence and severity of coronary artery
calcification using coronary CT (11). Thus, additional data
are needed to clarify the relationship between race and
CAC.
The Prospective Army Coronary Calcium (PACC)
project is an ongoing, prospective study evaluating the
utility of coronary CT as a screening tool for coronary heart
disease risk in active-duty U.S. Army men and women
between the ages of 40 to 45 years. This analysis evaluates
the relationships between CAC and race in this narrow-age
ranged, demographically diverse population. We hypothe-
sized that black and white study participants would have a
similar prevalence and severity of CAC.
METHODS
The Walter Reed Army Medical Center Department of
Clinical Investigation Human Use Committee approved
this study, for which the methods (12) and some prelimi-
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nary results have been previously described. Briefly, the
PACC cohort consists of active duty U.S. Army personnel
between the ages of 40 to 45 years who voluntarily partic-
ipated in the research study under informed consent at the
time of mandatory, periodic Army physical evaluation. The
study procedures included a health risk appraisal and other
validated questionnaires, serologic testing of cardiovascular
risks factors, and a coronary CT scan. All subjects were
asymptomatic and free of known cardiovascular disease at
the time of enrollment. Between October 1998 and August
2000, among 1,000 consecutive participants, 999 indicated a
specific racial affiliation and had a coronary CT scan. This
included white, non-Hispanic in 699 (69.9%) participants
and black, non-Hispanic in 194 (19.4%) participants.
Each participant provided details of their medical history,
including known diagnoses of hypertension, diabetes mel-
litus, and hypercholesterolemia. Smoking was self-reported
as current, recent (within 6 months), or remote (6
months) cigarette use. A family history of coronary heart
disease included a history of sudden death, myocardial
infarction, or coronary revascularization in a first degree
relative before the age of 55 years (males) or 65 years
(females). Height and weight were measured, and body
mass index (BMI) was calculated as weight/height2 (kg/m2).
Waist girth was measured to the nearest centimeter using a
tape on exposed skin at the level of the umbilicus in the
standing position with the arms and shoulders relaxed.
Resting blood pressure was measured using an automated
sphygmomanometer, and was recorded as the average of
three seated measurements taken 5 min apart. Hypertension
was defined as either a systolic blood pressure of 135 mm
Hg, a diastolic blood pressure of 85 mm Hg (13), or a
history of hypertension (treated or untreated). Fasting blood
was collected for the measurement of serum glucose, gly-
cosylated hemoglobin, insulin, homocysteine, lipopro-
tein(a), and fibrinogen. Low-density lipoprotein cholesterol
was measured using a direct assay. Standard 12-lead elec-
trocardiograms were evaluated by an investigator without
knowledge of the CAC score or other cardiovascular risk
factors. Left ventricular hypertrophy was classified accord-
ing to the methods of the Framingham study (14). The
metabolic syndrome was classified according to the recom-
mendations of the National Cholesterol Education Program
(15).
Coronary CT scanning and analysis. Coronary CT was
performed using an Imatron C-150LXP electron beam CT
scanner (Imatron Inc., San Bruno, California). Images were
obtained using a 40- to 50-slice (3-mm thickness) protocol
with image acquisition gated to 70% to 80% of the electro-
cardiographic RR interval while respirations were held.
Scans were interpreted in a blinded manner by an experi-
enced radiologist (I. M. F.) using the Agatston scoring
method (16). A focus of coronary calcium was defined as the
presence of four or more contiguous pixels with 130
Hounsfield U (field of view, 350 mm). A total CAC score
was determined from the sum of individual scores of the
four major epicardial coronary arteries. A scan was consid-
ered positive for CAC when the total CAC score was 0
(17).
Statistical analysis. Cardiovascular risk factor differences
between white and black subjects were explored. Risk factor
comparisons between groups of patients with and without
CAC using a threshold value of any detectable coronary
calcium (CAC score  0) were performed. Continuous
variables were compared using a t test for independent
groups. For comparison of CAC scores between groups,
data were log-transformed using the formula: log (CAC 
1). Categorical variables were compared using the chi-
squared test. The relationship between multiple cardiovas-
cular risk factors and the presence of CAC was assessed
using stepwise logistic regression analysis. Risk factor vari-
ables with a univariate relationship (p 0.05) to CAC were
entered into the model. Race, categorically defined as white
or black, socioeconomic status (military rank was used as a
surrogate), and education level (highest level attained) were
also entered into the model. All analyses were performed
using SPSS for Windows (version 10.05, SPSS Inc., Chi-
cago, Illinois). Data are presented as mean  SD. A
two-tailed p value of 0.05 was considered statistically
significant.
RESULTS
Table 1 displays the baseline demographics and cardiovas-
cular risk variables of the black and white study participants.
Overall, black individuals were significantly more likely to
be current smokers, and have hypertension. White patients
were more likely to have the metabolic syndrome. Among
measured variables, black individuals more commonly had
left ventricular hypertrophy and electrocardiographic ST-T-
wave abnormalities. They also had significantly higher mean
values for BMI, systolic and diastolic blood pressure, and
levels of high-density lipoprotein cholesterol, hemoglobin
A1C, and lipoprotein(a) than white participants. In com-
parison, white subjects had statistically higher serum triglyc-
eride levels.
Overall, the prevalence of CAC was 17.3%, and was
associated with BMI, waist girth, diastolic blood pressure,
high-density lipoprotein cholesterol, triglyceride level, he-
moglobin A1C, lipoprotein(a), and fibrinogen. White sub-
Abbreviations and Acronyms
BMI  body mass index
CAC  coronary artery calcium
CARDIA  Coronary Artery Risk Development In
young Adults study
coronary CT  coronary artery computed tomography
PACC  Prospective Army Coronary Calcium
project
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jects had nearly twice the prevalence of CAC as black
subjects (19.2% vs. 10.3%, p  0.004). The CAC preva-
lence and coronary CT scores for gender and racial sub-
groups are shown in Table 2. Coronary artery calcium was
more common in both white men (trend: p  0.06) and
white women (p 0.02). Overall, the mean CAC score was
also significantly higher for white than for black subjects.
No black woman had detectable CAC, and the mean CAC
score was significantly higher in white women (p  0.03).
Univariate associations between race and cardiovascular
risk variables were entered into a logistic regression model
for CAC, controlling for race and socioeconomic status.
After adjustment for these factors, race, BMI, and the
serum levels of triglycerides and lipoprotein(a) remained
statistically significant predictors of CAC (p  0.05). The
odds ratio for CAC in black individuals, after controlling for
these factors, was 0.39 (95% confidence interval, 0.20 to
0.78, p  0.007) (Table 3).
DISCUSSION
In this age-narrow screening population, the prevalence of
CAC was nearly 50% lower in black than in white individ-
uals. Furthermore, this difference widened after adjustment
for socioeconomic status, educational level, and the expected
race-related differences in the cardiovascular risk factor
profile. These data have important implications for the
generalizability of coronary CT score distributions of the
presence and severity of CAC within ethnic subgroups for
the purpose of cardiovascular risk determinations.
The biologic basis for differences between black and
white subjects in the presence of preclinical atherosclerosis is
partly founded in major interracial differences in cardiovas-
cular risk factors. Whereas hypertension, diabetes, and
obesity are more prevalent in black individuals, lipid profile
abnormalities (particularly lower high-density lipoprotein
cholesterol and higher triglyceride levels) are more prevalent
Table 1. Cardiovascular Risk Variables Among White and Black Patients Studied With
Coronary CT
White
N  699
Black
N  194 p Value
Coronary CT
Any CAC present (%) 134 (19.2) 20 (10.3) 0.004
Mean CAC score (%) 15  93 7  58 0.003
Hypertension (%) 44 (6.3) 32 (16.5)  0.001
ECG LVH present (%) 30 (4.3) 26 (13.4)  0.001
ST-T-wave abnormalities (%) 25 (3.6) 34 (18.1)  0.001
Cigarette smoking, current (%) 33 (4.7) 31 (16.1)  0.001
Cigarette smoking, former (%) 134 (19.2) 50 (25.8)  0.001
Metabolic syndrome (%) 70 (10.0) 8 (4.1) 0.01
Family history of coronary heart disease (%) 136 (19.5) 32 (16.5) 0.43
Current statin medication use (%) 21 (3.0) 8 (4.1) 0.40
Body mass index (kg/m2) 27.2  3.1 28.2  3.6 0.03
Waist girth (cm) 93.0  9.8 91.0  9.7 0.97
Blood pressure, systolic (mm Hg) 122  12 124  15 0.001
Blood pressure, diastolic (mm Hg) 76  9 78  10 0.001
Total cholesterol (mg/dl) 202  36 202  37 0.90
LDL cholesterol (mg/dl) 131  33 129  35 0.33
HDL cholesterol (mg/dl) 51  13 57  16 0.003
Trigylcerides (mg/dl) 130  91 99  57 0.001
Hemoglobin AIC (%) 5.5  0.6 5.7  0.6 0.017
Fasting glucose (mg/dl) 91  11 90  10 0.90
Lipoprotein(a) (mg/dl) 27  33 58  45 0.000
Homocysteine (mol/l) 9.5  2.6 9.6  2.7 0.34
Fibrinogen (mg/dl) 307  58 324  61 0.69
Insulin (U/ml) 8.2  7.2 9.3  6.6 0.96
C-reactive protein (mg/dl) 0.26  0.89 0.26  0.42 0.79
CAC  coronary artery calcium; CT  computed tomography; ECG  electrocardiogram; HDL  high-density lipoprotein;
LDL  low-density lipoprotein; LVH  left ventricular hypertrophy.
Table 2. Coronary Calcium Scores and Prevalence in Black and White Subjects
Overall Men Women
CAC Score Prevalence n CAC Score Prevalence n CAC Score Prevalence
Black 7  58 20/194 (10.3%) 145 9  67 20/145 (13.8%) 49 0 0/49 (0%)
White 15  93 134/698 (19.2%) 597 16  100 124/597 (20.8%) 97 4  27 10/97 (10.3%)
p Value 0.003 0.004 0.053 0.057 0.020 0.017
CAC  coronary artery calcium.
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in whites. However, current evidence from pathology stud-
ies of early atherosclerosis (18,19) and ultrasound studies of
carotid intima-media thickness in asymptomatic individuals
(20–22) indicate that, after controlling for differences in risk
factors and socioeconomic status, race does not have an
independent relationship to atherosclerosis.
Extending this assumption to the process of atheroscle-
rosis calcification may be a mistake. Indeed, the use of
coronary CT-derived CAC scores as a surrogate for athero-
sclerosis burden in different racial groups assumes that the
process of coronary calcification occurs as a race-
independent phenomenon. Doherty et al. (10) showed a
CAC prevalence of 36% in black individuals, versus 60% in
whites, using digital fluoroscopy in a middle-aged to elderly,
primarily male and higher-risk population from the South
Bay Heart Watch study. Furthermore, these differences
remained after adjustment for cardiovascular risk factors. A
recent study (23) of the very elderly also found that black
individuals were less likely to have CAC, a difference that
persisted after adjustment for age differences between racial
groups. Our findings in middle-aged, asymptomatic white
and black subjects are in agreement with these investigators,
and extend the lower prevalence of coronary calcium in
black patients in the South Bay Heart Watch cohort to
include both men and women.
These data differ from the published findings of the
CARDIA study, which reported a similar prevalence of
CAC in blacks and whites using coronary CT in the year 10
examination (11). These results from the CARDIA study
are particularly notable because, similar to the current study,
CARDIA was also a screening study of younger individuals.
In general, we recommend that caution must be used in
interpreting data on subclinical calcified atherosclerosis
from cohorts of racially and geographically over-sampled
participants that could be biased by genetic clustering.
However, the discrepancy with the CARDIA study appears
to be most likely a result of false positive studies from
obesity-related CT scan artifacts (personal communication,
Robert Detrano, MD, PhD, January 2002). This is sup-
ported by a recently presented analysis (24) of CARDIA
year 15 coronary CT scans that refutes the original CAR-
DIA publication (11) by showing a lower prevalence of
CAC in black individuals, although this finding was re-
stricted to men. Thus, the current evidence favors the
conclusion that black individuals are substantially less likely
to have CAC.
Despite the lower prevalence of CAC in black individuals
within the South Bay Heart Watch, the associated cardio-
vascular event rate was over twofold higher than in whites
(10). Consistent with the established greater cardiovascular
event burden in ethnic minorities, in part due to a shift from
atherosclerotic to hypertensive vascular disease as a cause of
death (25,26), these race-related differences in CAC, and
the altered relationship to cardiovascular events, suggest that
the application of race-nonspecific CAC distributions to
black individuals and conceivably other ethnic groups will
lead to inaccurate atherosclerosis burden assessments and
inherent inaccuracy in the cardiovascular risk assessment.
Although the present study did not have sufficient power to
definitively address the relationship between gender, race,
and coronary calcification, this study appears to support that
this limitation would extend to both black men and women.
In comparison, assessments of noncalcified atherosclerosis
using technologies, such as B-mode carotid ultrasound, have
not demonstrated a consistent pattern of major interracial
differences in atherosclerosis burden (20,21). Thus, in mi-
norities, atherosclerosis burden testing using methods other
than coronary CT is most appropriate until data on race-
specific CAC distributions and its prognostic relationships
are known.
There is no definitive causal mechanism linking ethnicity
with coronary calcification; however, racial differences in
osteoporosis (8,27) and its complications (28) establish a
precedence for interracial variability in the regulation of
tissue calcification. Atherosclerosis calcification is an active,
regulated process similar to osteogenesis that is partially
Table 3. Logistic Regression Coefficients and Confidence Intervals for a Multivariate Model
Evaluating Associations With Coronary Artery Calcium
Variables
Odds
Ratio
95% CI for Odds Ratio
p ValueLower Upper
Body mass index (per kg/m2) 1.113 1.039 1.193 0.002
Black race 0.394 0.200 0.776 0.007
Triglycerides (per mg/dl) 1.003 1.001 1.006 0.011
Lipoprotein(a) (per mg/dl) 1.008 1.003 1.013 0.003
Systolic blood pressure (per mm Hg) 1.008 0.987 1.030 0.456
HDL-C (per mg/dl) 1.005 0.988 1.023 0.547
Left ventricular hypertrophy 0.758 0.325 1.771 0.523
ST-T-abnormalities 1.190 0.508 2.791 0.688
Former smoker 0.815 0.313 2.122 0.675
Military rank (pay grade) 1.022 0.917 1.139 0.691
Highest education level 1.201 0.861 1.676 0.280
Hemoglobin AIC (per 0.1%) 1.038 0.750 1.436 0.822
Fibrinogen (per mg/dl) 1.000 0.996 1.003 0.894
CI  confidence interval; HDL-C  high-density lipoprotein cholesterol.
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influenced by hormonal factors. For example, higher levels
of 1,25 dihydroxy vitamin D predict lower coronary calcium
mass, regardless of race (7,9), although there is controversy
on this subject (29). Genetic factors may also contribute to
race-related differences in CAC and concomitant athero-
sclerosis. Although specific genetic associations have not yet
been identified, chief among these is matrix gla protein
polymorphisms (30), which may provide a relative protec-
tion from atherosclerosis tissue calcification (31). The in-
creasing frequency of interracial marriages and racial admix-
tures will create an opportunity to test these genetic
hypotheses as the racial constructs of black and white, or
Hispanic and Asian, become increasingly blurred (32).
CONCLUSIONS
Cardiovascular risk assessments incorporating CAC assume
that population-based CAC distributions can be evenly
generalized to all racial groups. Currently available data in
populations ranging in age from middle-aged to the elderly
support that this assumption is incorrect, based upon the
substantially lower prevalence of CAC, but not necessarily
lower rates of incident cardiovascular events, in blacks
compared with whites. Thus, the cross-ethnic generaliza-
tion of current population-based CAC distributions and
cardiovascular risk assessments is premature until the rela-
tionships between race, CAC, and cardiovascular outcomes
are specifically established in ethnic minorities.
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